• Je něco špatně v tomto záznamu ?

Next-Generation Sequencing in Lung Cancer Patients: A Comparative Approach in NSCLC and SCLC Mutational Landscapes

C. Pop-Bica, CA. Ciocan, C. Braicu, A. Haranguș, M. Simon, A. Nutu, LA. Pop, O. Slaby, AG. Atanasov, R. Pirlog, N. Al Hajjar, I. Berindan-Neagoe

. 2022 ; 12 (3) : . [pub] 20220313

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22009793

BACKGROUND: Lung cancer remains one of the most diagnosed malignancies, being the second most diagnosed cancer, while still being the leading cause of cancer-related deaths. Late diagnosis remains a problem, alongside the high mutational burden encountered in lung cancer. METHODS: We assessed the genetic profile of cancer genes in lung cancer using The Cancer Genome Atlas (TCGA) datasets for mutations and validated the results in a separate cohort of 32 lung cancer patients using tumor tissue and whole blood samples for next-generation sequencing (NGS) experiments. Another separate cohort of 32 patients was analyzed to validate some of the molecular alterations depicted in the NGS experiment. RESULTS: In the TCGA analysis, we identified the most commonly mutated genes in each lung cancer dataset, with differences among the three histotypes analyzed. NGS analysis revealed TP53, CSF1R, PIK3CA, FLT3, ERBB4, and KDR as being the genes most frequently mutated. We validated the c.1621A>C mutation in KIT. The correlation analysis indicated negative correlation between adenocarcinoma and altered PIK3CA (r = -0.50918; p = 0.0029). TCGA survival analysis indicated that NRAS and IDH2 (LUAD), STK11 and TP53 (LUSC), and T53 (SCLC) alterations are correlated with the survival of patients. CONCLUSIONS: The study revealed differences in the mutational landscape of lung cancer histotypes.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22009793
003      
CZ-PrNML
005      
20220425131553.0
007      
ta
008      
220420s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/jpm12030453 $2 doi
035    __
$a (PubMed)35330454
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Pop-Bica, Cecilia $u Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania
245    10
$a Next-Generation Sequencing in Lung Cancer Patients: A Comparative Approach in NSCLC and SCLC Mutational Landscapes / $c C. Pop-Bica, CA. Ciocan, C. Braicu, A. Haranguș, M. Simon, A. Nutu, LA. Pop, O. Slaby, AG. Atanasov, R. Pirlog, N. Al Hajjar, I. Berindan-Neagoe
520    9_
$a BACKGROUND: Lung cancer remains one of the most diagnosed malignancies, being the second most diagnosed cancer, while still being the leading cause of cancer-related deaths. Late diagnosis remains a problem, alongside the high mutational burden encountered in lung cancer. METHODS: We assessed the genetic profile of cancer genes in lung cancer using The Cancer Genome Atlas (TCGA) datasets for mutations and validated the results in a separate cohort of 32 lung cancer patients using tumor tissue and whole blood samples for next-generation sequencing (NGS) experiments. Another separate cohort of 32 patients was analyzed to validate some of the molecular alterations depicted in the NGS experiment. RESULTS: In the TCGA analysis, we identified the most commonly mutated genes in each lung cancer dataset, with differences among the three histotypes analyzed. NGS analysis revealed TP53, CSF1R, PIK3CA, FLT3, ERBB4, and KDR as being the genes most frequently mutated. We validated the c.1621A>C mutation in KIT. The correlation analysis indicated negative correlation between adenocarcinoma and altered PIK3CA (r = -0.50918; p = 0.0029). TCGA survival analysis indicated that NRAS and IDH2 (LUAD), STK11 and TP53 (LUSC), and T53 (SCLC) alterations are correlated with the survival of patients. CONCLUSIONS: The study revealed differences in the mutational landscape of lung cancer histotypes.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ciocan, Cristina Alexandra $u Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania
700    1_
$a Braicu, Cornelia $u Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania $1 https://orcid.org/0000000230554747
700    1_
$a Haranguș, Antonia $u Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania $u Leon Daniello Pulmonology Hospital, 400332 Cluj-Napoca, Romania $1 https://orcid.org/0000000288270501
700    1_
$a Simon, Marioara $u Leon Daniello Pulmonology Hospital, 400332 Cluj-Napoca, Romania
700    1_
$a Nutu, Andreea $u Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania $1 https://orcid.org/0000000224360903
700    1_
$a Pop, Laura Ancuta $u Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania $1 https://orcid.org/0000000258060220
700    1_
$a Slaby, Ondrej $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, 62500 Brno, Czech Republic $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic
700    1_
$a Atanasov, Atanas G $u Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, 05-552 Magdalenka, Poland $u Institute of Neurobiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria $u Department of Pharmaceutical Sciences, University of Vienna, 1010 Vienna, Austria $u Ludwig Boltzmann Institute for Digital Health and Patient Safety, Medical University of Vienna, 1090 Vienna, Austria $1 https://orcid.org/0000000325450967
700    1_
$a Pirlog, Radu $u Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania $1 https://orcid.org/0000000320265543
700    1_
$a Al Hajjar, Nadim $u Regional Institute of Gastroenterology and Hepatology, 400000 Cluj-Napoca, Romania
700    1_
$a Berindan-Neagoe, Ioana $u Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania $1 https://orcid.org/0000000158281325
773    0_
$w MED00203320 $t Journal of personalized medicine $x 2075-4426 $g Roč. 12, č. 3 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35330454 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220420 $b ABA008
991    __
$a 20220425131551 $b ABA008
999    __
$a ind $b bmc $g 1784398 $s 1160991
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 12 $c 3 $e 20220313 $i 2075-4426 $m Journal of personalized medicine $n J. pers. med. $x MED00203320
LZP    __
$a Pubmed-20220420

Najít záznam

Citační ukazatele

    Možnosti archivace